AA
BEAT

AlphaMark Advisors’s BioTelemetry, Inc. BEAT Stock Holding History

AlphaMark Advisors’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-16,740
Closed -$1.08M – 540
2018
Q3 		$1.08M Sell
16,740
-6,337
-27% -$354K 0.43% 46
2018
Q2 		$1.04M Sell
23,077
-7,300
-24% -$291K 0.42% 54
2018
Q1 		$943K Sell
30,377
-5,845
-16% -$192K 0.4% 53
2017
Q4 		$1.08M Buy
36,222
+5,742
+19% +$166K 0.42% 50
2017
Q3 		$1.01M Buy
+30,480
New +$1.06M 0.43% 53

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AlphaMark Advisors's BEAT Position: Q4 2018 in Review

AlphaMark Advisors sold out of BioTelemetry, Inc. (BEAT) in Q4 2018, closing a stake of 16,740 shares — an estimated $1.08M sold.

AlphaMark Advisors first reported a position in BEAT in Q3 2017 and held it in 5 quarters. The position peaked at $1.08M in Q4 2017. 281 funds tracked by Wall St. Rank hold BEAT as of Q4 2018.

  • AlphaMark Advisors reported no remaining BioTelemetry, Inc. position as of Q4 2018 after selling out during the quarter.
  • AlphaMark Advisors sold 16,740 BioTelemetry, Inc. shares in Q4 2018, an estimated $1.08M.
  • AlphaMark Advisors first reported a position in BioTelemetry, Inc. in Q3 2017 and held it in 5 quarters.
  • AlphaMark Advisors's BioTelemetry, Inc. position peaked at $1.08M in Q4 2017.
  • 281 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2018.

Based on AlphaMark Advisors's 13F filing for Q4 2018, filed 6 Feb 2019.